Regeneron Pharmaceuticals' Interest & Investment Income fell 114.92% to -$6.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$25.1 million, marking a year-over-year decrease of 249.12%. This contributed to the annual value of -$25.1 million for FY2017, which is 249.12% down from last year.
Regeneron Pharmaceuticals' Interest & Investment Income amounted to -$6.0 million in Q4 2017, which was up 2.38% from -$6.2 million recorded in Q3 2017.
Over the past 5 years, Regeneron Pharmaceuticals' Interest & Investment Income peaked at $2.1 million during Q3 2015, and registered a low of -$18.2 million during Q4 2015.
Its 3-year average for Interest & Investment Income is -$3.9 million, with a median of -$2.7 million in 2016.
As far as peak fluctuations go, Regeneron Pharmaceuticals' Interest & Investment Income surged by 105.48% in 2014, and later slumped by 1,566.67% in 2016.
Over the past 5 years, Regeneron Pharmaceuticals' Interest & Investment Income (Quarterly) stood at -$2.3 million in 2013, then surged by 75.79% to $1.7 million in 2014, then declined by 1.43% to -$18.2 million in 2015, then spiked by 84.58% to -$2.8 million in 2016, then tumbled by 114.92% to -$6.0 million in 2017.
Its last three reported values are -$6.0 million in Q4 2017, -$6.2 million for Q3 2017, and -$5.4 million during Q2 2017.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value